Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -1.67% 29.50p 29.00p 30.00p 30.00p 29.50p 30.00p 26,200 15:41:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -3.2 -6.3 - 21.58

Evgen Pharma (EVG) Latest News

More Evgen Pharma News
Evgen Pharma Takeover Rumours

Evgen Pharma (EVG) Share Charts

1 Year Evgen Pharma Chart

1 Year Evgen Pharma Chart

1 Month Evgen Pharma Chart

1 Month Evgen Pharma Chart

Intraday Evgen Pharma Chart

Intraday Evgen Pharma Chart

Evgen Pharma (EVG) Discussions and Chat

Evgen Pharma (EVG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Evgen Pharma trades in real-time

Evgen Pharma (EVG) Top Chat Posts

DateSubject
24/9/2016
09:20
Evgen Pharma Daily Update: Evgen Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 30p.
Evgen Pharma has a 4 week average price of 28.40p and a 12 week average price of 22.22p.
The 1 year high share price is 43.50p while the 1 year low share price is currently 14.75p.
There are currently 73,142,862 shares in issue and the average daily traded volume is 22,019 shares. The market capitalisation of Evgen Pharma is £21,577,144.29.
25/7/2016
18:47
timbo003: Presumably this new article on Proactiveinvestor was the catalyst for the excitement today: http://www.proactiveinvestors.co.uk/companies/news/128572/evgen-pharma-and-the-power-of-plants-for-potential-drug-breakthrough-128572.html It's well written but contains no new news, so it wouldn't surprise me if the share price drifts back down again. I suspect the next significant news will be MRHA approval for the Metastatic breast cancer study
30/10/2011
19:43
call-logger: Subject to the Court sanctioning the Scheme and the satisfaction of certain other outstanding conditions, it is expected that the last day for dealings in Evolution Shares will be 6 December 2011 and the Scheme will become effective on 7 December 2011. If you're selling, the takeover date doesn't really matter to you. The share price is now purely based on the market's view of Investec
08/11/2009
18:17
plast: well if that is the result to the share price, then they can sell some more.
08/1/2008
19:48
msy: No share price movement to the following news? BES could make full bid for Evolution if strategic alliance goes well LISBON (Thomson Financial) - Banco Espirito Santo could make a full bid for the Evolution Group, in which it bought a 9.95 pct stake yesterday, if the strategic alliance between the Portuguese bank and the UK broker goes well, the Daily Telegraph reported, without citing a source. According to the newspaper, BES bought the stake in Evolution to offer international clients access to the London market through the UK-based financial holding's investment arm. If the arrangement works well, BES may make an offer for the whole of the UK business which is worth 260 mln stg, the paper said. Yesterday, BES investment unit BESI said it acquired its 9.95 pct stake for around 26.1 mln stg (about 35.5 mln eur). Evolution might be attractive to a buyer because the volatile earnings from its investment banking business were offset by more steady profits from its asset-management business, gained when it bought Williams de Broe from ING in 2006, the paper added.
11/10/2007
15:50
eastbourne1982: moving very strongly this afternoon and starting to build up some decent momemtum, could be the start of a recovery in the share price
08/10/2007
11:58
eastbourne1982: any ideas what is going on here, pretty much at a 3 - 4 year in terms of share price, all seems very strange as there cannot be a lot wrong with this company, I will continue to hold, may just take a little longer to see £1.30 again !!
28/3/2007
09:08
seagreen: Incredible change around in the shareholders register over the last couple of months with well known value seekers and activist shareholders famous for extracting value or seeking long term growth coming on board with large stakes and there is no way they have come on board because Evolution is the city darling especially after TXO etc Surely it means they think the sum of the parts and the cash must be worth a lot more than the current share price be it as one company or as individual companies...Anyway I have gone long a few to see what happens
26/11/2004
12:56
jonck: EVG may have paid the fine, but what compensation is that to those who lost as a result of their shorting. Get the rose tinted glasss off and really look at what is happening. I have no idea what affect further lawsuits will have on EVG share price but EVG screwed investors and the ball is in their hands to sort it out the best way they can. It is EVG policies which are endangering your share value not the RSV action group or the City boys who are negative about them. Bury your head in the sand if you want, and whatever the grievances those affected by the shorting have can get stuffed, but that will not make them go away. The rules where not stretched a little, they were stretched beyond belief and all at the cost of investors. Well, it looks to me like this time it may well end up being at EVG's own cost and sad as it is to see EVG shareholders losing value in their investments its a fact of life these things happen all the time when lawsuits are brought against a company. If I was big holder of EVG shares I would be demanding from the company to know what the hell was going on and how they got into this mess (which we now know the answers to) and what they are doing to get out of it without further causing turbulant waves. I have every support for the RSV group in whatever thei next action may be as they deserve compensation for EVG's actions and also they are bring to light many market tactics that are against the best interest of ALL investors. WAKE UP guys, stop ramping , stop deramping EVG and stop whinging about each other - just look at the facts and start discussing what the future really holds for EVG. Then maybe you can decide if it is a wise move to invest or short the shares.
13/9/2003
10:24
rivaldo: On hols at present, but have to log in every so often! Looks like the stake in Wolfson may have been diluted a bit, as none of the press coverage mentioned EVG's stake. So probably around 1% or so, but still worth maybe 2m upwards. More importantly, EVG announced the following which seems to have gone unnoticed. Evidently IP2IPO are gearing up for flotation asap. No wonder the EVG share price is strong. I'd guess 80p will be breached fairly soon, and if IP2IPO is floated IMO we will be over 120p++ in short order. "The Evolution Group Plc ('the Company') announces that Dr Bruce Smith, a non-executive director of IP2IPO Group Limited ('IP2IPO'), an intellectual property commercialisation company which is a subsidiary of the Company, has been appointed as non-executive chairman of IP2IPO." "In conjunction with Dr Smith's appointment as non-executive chairman, David Norwood will become the full-time Chief Executive of IP2IPO. Mr Norwood will step down as an executive director of The Evolution Group Plc with immediate effect but will remain on the Company's board as a non-executive director. David Norwood, who has served as IP2IPO's Chief Executive on a part time basis since November 2002 has a wide range of experience in early and mid-stage technology companies. In July 1999, he founded IndexIT Partnership Limited, a technology advisory boutique which was acquired by Beeson Gregory Group plc. Mr Norwood was a director of Beeson Gregory Group plc and was key to the origination of Beeson Gregory's £20m partnership with Oxford University, which laid the foundation for the formation of IP2IPO."
25/5/2002
13:56
pork belly: "...paving the way for an all-share bid from Evolution within a fortnight." Just confirms my earlier post. EVG shares will be HEAVILY diluted. Porky My earlier post below. PS I am not shorting or trying to de-ramp with any alternative agenda. I just believe that EVG share price could/should drop. I am VERY interested in EVG but need to see what hapens before jumping aboard. ------------------------------------------------------------------ At 124p, this values BGG at 85.5m. EVG have 26.5m cash ,"but will need to be all cash to succeed." Possible issue of NEW shares to the tune of 59m ? EVG have 116m shares in issue at present. If EVG successfuly place the shares @ 70p, then this would equate to a total of 200.4m shares in issue (an extra 84.4m shares)...an immediate decrease in share price to around 43.5p per share !!!!! BGG have,at 31 DEC 01, 13.1m cash. see http://www.ukwire.co.uk/cgi-bin/articles/200203220830043965T.html So, this could value EVG at around 43.5p but with only half of its existing cash pile ! Although great for the long term,it is a little worrying for the short term. Watching from the sidelines with interest as i believe that EVG have top quality management but am a little concerned as to how they intend to pay for BGG. Cheers,Porky.
Evgen Pharma share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20160925 05:28:04